The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 16, 2019

Filed:

Apr. 14, 2016
Applicant:

Metabrain Research, Chilly Mazarin, FR;

Inventors:

Sophie N. Raynal, Paris, FR;

Micheline R. Kergoat, Les Ulis, FR;

Valerie Autier, Gif sur Yvette, FR;

Christine G. Charon, Gometz le Chantel, FR;

Jean-Denis Durand, Montreuil Sous Bois, FR;

Franck F. Lepifre, Saclay, FR;

Annick M. Audet, Leudeville, FR;

Assignee:

METABRAIN RESEARCH, Chilly Mazarin, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/15 (2006.01); A61K 31/50 (2006.01); A61P 21/00 (2006.01); A61K 31/165 (2006.01); A61K 31/197 (2006.01); A61K 31/216 (2006.01); A61K 31/495 (2006.01); A61K 31/4402 (2006.01); A61K 31/4406 (2006.01);
U.S. Cl.
CPC ...
A61K 31/197 (2013.01); A61K 31/15 (2013.01); A61K 31/165 (2013.01); A61K 31/216 (2013.01); A61K 31/4402 (2013.01); A61K 31/4406 (2013.01); A61K 31/495 (2013.01); A61K 31/50 (2013.01); A61P 21/00 (2018.01);
Abstract

This invention relates to oxime and alkoxy derivatives of the general formula (I), or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof for use as a medicament for the treatment and/or prevention of muscle atrophy in mammals and/or for limiting muscular atrophy in mammals and/or to promote muscle growth in exercising mammals aimed at increasing muscle mass and quality, preventing the occurrence of symptoms of sarcopenia related to age or rehabilitation after a muscle loss, age-related muscle atrophy and/or the consequences of drug therapy and/or immobilization and/or cachexia.


Find Patent Forward Citations

Loading…